当前位置: X-MOL 学术Fetal Neonatal › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Antenatal magnesium sulfate to prevent cerebral palsy
Fetal & Neonatal ( IF 4.4 ) Pub Date : 2021-07-07 , DOI: 10.1136/archdischild-2021-321817
Amy K Keir 1, 2, 3 , Emily Shepherd 4 , Sarah McIntyre 5 , Alice Rumbold 2, 4 , Charlotte Groves 3 , Caroline Crowther 6 , Emily Joy Callander 7
Affiliation  

Magnesium sulfate given to women before birth at <30 weeks’ gestation reduces the risk of cerebral palsy in their children. Our study aimed to assess the impact of a local quality improvement programme, primarily using plan-do-study-act cycles, to increase the use of antenatal magnesium sulfate. After implementing our quality improvement programme, an average of 86% of babies delivered at <30 weeks’ gestation were exposed to antenatal magnesium sulfate compared with a historical baseline rate of 63%. Our study strengthens the case for embedding quality improvement programmes in maternal perinatal care to reduce the impact of cerebral palsy on families and society. Data (de-identified only) are available upon reasonable request.

中文翻译:

产前硫酸镁预防脑瘫

在小于 30 周的孕周内给予妇女出生前的硫酸镁可降低其孩子患脑瘫的风险。我们的研究旨在评估当地质量改进计划的影响,主要使用计划-学习-行动周期,以增加产前硫酸镁的使用。在实施我们的质量改进计划后,平均 86% 的孕周小于 30 周分娩的婴儿暴露于产前硫酸镁,而历史基线率为 63%。我们的研究加强了在孕产妇围产期护理中嵌入质量改进计划以减少脑瘫对家庭和社会的影响的理由。可根据合理要求提供数据(仅去识别化)。
更新日期:2021-07-08
down
wechat
bug